Your browser is no longer supported. Please, upgrade your browser.
PKI PerkinElmer, Inc. monthly Stock Chart
PKI [NYSE]
PerkinElmer, Inc.
IndexS&P 500 P/E44.99 EPS (ttm)2.65 Insider Own0.30% Shs Outstand111.12M Perf Week0.20%
Market Cap13.25B Forward P/E21.19 EPS next Y5.62 Insider Trans-11.43% Shs Float110.47M Perf Month16.25%
Income294.10M PEG2.65 EPS next Q1.38 Inst Own92.90% Short Float2.52% Perf Quarter28.34%
Sales2.98B P/S4.45 EPS this Y-2.70% Inst Trans-3.68% Short Ratio2.87 Perf Half Y24.53%
Book/sh24.84 P/B4.79 EPS next Y8.20% ROA3.50% Target Price121.54 Perf Year44.11%
Cash/sh1.75 P/C67.91 EPS next 5Y16.95% ROE8.30% 52W Range62.91 - 123.21 Perf YTD22.61%
Dividend0.28 P/FCF51.73 EPS past 5Y7.70% ROI6.50% 52W High-3.38% Beta1.42
Dividend %0.24% Quick Ratio1.30 Sales past 5Y5.20% Gross Margin50.30% 52W Low89.24% ATR2.95
Employees13000 Current Ratio1.80 Sales Q/Q0.60% Oper. Margin11.00% RSI (14)64.61 Volatility2.22% 2.30%
OptionableYes Debt/Eq0.73 EPS Q/Q-5.20% Profit Margin7.60% Rel Volume1.17 Prev Close122.09
ShortableYes LT Debt/Eq0.73 EarningsJul 28 AMC Payout13.60% Avg Volume968.93K Price119.05
Recom2.40 SMA205.89% SMA5013.73% SMA20028.24% Volume1,140,661 Change-2.49%
Jul-29-20Upgrade CFRA Hold → Buy
Jan-08-20Initiated Wells Fargo Equal Weight $105
Jan-07-20Initiated Citigroup Neutral $100
Jan-02-20Upgrade Evercore ISI In-line → Outperform
Nov-15-19Initiated Stifel Buy
Oct-31-19Downgrade Piper Jaffray Overweight → Neutral $104 → $89
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $105
May-30-19Initiated Wolfe Research Peer Perform
Apr-09-19Upgrade Goldman Neutral → Buy $115
Jan-03-19Initiated Needham Hold
Nov-02-18Downgrade Janney Buy → Neutral
Oct-09-18Initiated UBS Neutral
Sep-10-18Reiterated Deutsche Bank Hold $88 → $93
Dec-19-17Upgrade BofA/Merrill Underperform → Neutral
Sep-26-17Resumed Goldman Neutral $67
Jul-13-17Initiated Wells Fargo Market Perform
Feb-03-17Downgrade BofA/Merrill Neutral → Underperform
Jan-18-17Initiated Deutsche Bank Hold $55
Aug-05-16Downgrade Mizuho Buy → Neutral $56
May-06-16Reiterated Stifel Buy $51 → $59
Aug-06-20 09:27AM  
09:26AM  
09:26AM  
09:22AM  
Aug-05-20 09:47AM  
09:08AM  
Aug-04-20 05:53PM  
05:39PM  
08:14AM  
Aug-03-20 12:00PM  
Jul-30-20 12:20PM  
Jul-29-20 12:35PM  
09:42AM  
Jul-28-20 10:31PM  
06:05PM  
04:15PM  
09:20AM  
Jul-27-20 08:34PM  
08:34AM  
07:00AM  
Jul-24-20 07:43PM  
Jul-23-20 04:15PM  
09:29AM  
Jul-22-20 07:28AM  
Jul-21-20 12:10PM  
08:00AM  
Jul-20-20 03:05AM  
Jul-17-20 12:00PM  
Jul-13-20 11:08AM  
08:38AM  
08:00AM  
Jun-20-20 03:00AM  
Jun-19-20 09:13AM  
Jun-18-20 03:14PM  
10:49AM  
Jun-12-20 12:34PM  
Jun-04-20 11:31AM  
08:48AM  
May-20-20 04:15PM  
May-18-20 09:44AM  
09:28AM  
07:17AM  
May-15-20 03:04PM  
May-06-20 10:23AM  
06:35AM  
01:01AM  
May-05-20 05:35PM  
04:15PM  
09:15AM  
May-03-20 03:45PM  
May-01-20 04:15PM  
Apr-30-20 04:15PM  
Apr-28-20 12:33PM  
Apr-21-20 06:08PM  
Apr-20-20 03:39PM  
Apr-14-20 08:30AM  
Apr-13-20 04:15PM  
11:01AM  
Mar-30-20 04:41AM  
Mar-27-20 09:44AM  
Mar-26-20 10:25AM  
Mar-25-20 07:01AM  
Mar-24-20 05:32PM  
05:13PM  
Mar-18-20 11:32AM  
06:26AM  
Mar-17-20 02:08PM  
08:49AM  
Mar-09-20 11:57AM  
06:00AM  
Mar-08-20 10:25AM  
Mar-02-20 08:30AM  
Feb-26-20 11:30AM  
Feb-07-20 01:01PM  
Jan-29-20 05:22AM  
Jan-28-20 02:23PM  
08:59AM  
Jan-27-20 05:35PM  
04:15PM  
Jan-23-20 04:15PM  
Jan-21-20 06:41AM  
Jan-20-20 12:30PM  
Jan-16-20 02:51AM  
Jan-13-20 05:54PM  
Jan-08-20 12:34PM  
Jan-07-20 04:15PM  
Jan-03-20 08:52AM  
Dec-30-19 02:08PM  
08:29AM  
Dec-19-19 04:15PM  
Dec-13-19 09:20AM  
Dec-08-19 07:16AM  
Dec-07-19 08:26PM  
Dec-03-19 03:42PM  
Nov-18-19 08:19AM  
Nov-08-19 04:15PM  
Nov-06-19 08:50AM  
Nov-03-19 02:05AM  
Oct-31-19 09:34AM  
Oct-30-19 06:05PM  
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophym, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldberg Joel SPlease See RemarksJul 31Option Exercise43.0123,3871,005,87595,179Aug 03 04:05 PM
Goldberg Joel SPlease See RemarksJul 31Sale117.8423,3872,755,82571,792Aug 03 04:05 PM
Okun AndrewPlease See RemarksJul 29Option Exercise52.654,699247,40217,009Jul 30 06:42 PM
Okun AndrewPlease See RemarksJul 29Sale120.006,699803,88010,310Jul 30 06:42 PM
Tereau Daniel RPlease See RemarksJun 15Option Exercise43.743,242141,78912,879Jun 16 04:06 PM
Tereau Daniel RPlease See RemarksJun 15Sale95.225,452519,1397,427Jun 16 04:06 PM
Barrett PeterDirectorMay 28Option Exercise42.094,750199,90429,552May 29 04:06 PM
Barrett PeterDirectorMay 28Sale100.117,552756,03822,001May 29 04:06 PM
MICHAS ALEXIS PDirectorFeb 10Option Exercise30.51752,28861,691Feb 11 04:16 PM
MICHAS ALEXIS PDirectorFeb 05Option Exercise30.515,526168,59863,386Feb 06 04:05 PM
MICHAS ALEXIS PDirectorFeb 05Sale96.231,777171,00261,609Feb 06 04:05 PM
Okun AndrewPlease See RemarksDec 04Option Exercise52.659,398494,80518,280Dec 05 04:05 PM
Okun AndrewPlease See RemarksDec 04Sale90.8711,9841,088,9866,296Dec 05 04:05 PM
Witz PascaleDirectorNov 21Sale90.671,04394,5692,446Nov 22 04:05 PM
MICHAS ALEXIS PDirectorAug 30Sale82.562,000165,12057,642Sep 03 04:05 PM